echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > Int J Radia Oncol: The pain of cancer radiotherapy, expected to be solved by FLASH proton radiotherapy

    Int J Radia Oncol: The pain of cancer radiotherapy, expected to be solved by FLASH proton radiotherapy

    • Last Update: 2020-06-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Radiotherapy is one of the main methods of cancer treatment, according to statistics, about 70% of cancer patients currently need to use radiation therapy in the course of cancer treatmentHowever, this treatment requires patients to be exposed to radiation for long periods of time, large areas, often prone to damage to normal cells in the body, resulting in hair loss, tiredness and other side effectsIs there a more effective and safer radiotherapy solution? Researchers at the University of Pennsylvania have designed a new proton FLASH radiation therapy system that can precisely control beam flux in milliseconds, killing cancer cells while effectively avoiding damage to normal tissue, which could represent a sea change in the field of oncology in the futurethe report was published recently in The International Journal of Radiation Oncology, Biology, and PhysicsThe magazine is the official journal of the American Society of Radiotherapy and Oncology (ASTRO), known as the Redskins journal in the field of radiation oncology, and the most influential magazine in the field of international oncology radiotherapyexperiment, researchers designed and built a novel "FLASH" radiotherapy (RT) device that uses double-scattered protons to provide FLASH (60-100Gy/s) or standard (0.5-1 Gy/s) dose rates in computer tomography (CT)The researchers used the device to compare the effects of FLASH proton radiotherapy and standard proton radiotherapy (RPT) on mice withpancreastumorsthe establishment of proton radiotherapy schematics
    measured by adding EdU, in the study of acute intestinal injury after 15 Gy full-abdominal proton radiotherapy, the number of nest proliferation cells per cryogenic cell in FLASH proton radiotherapy mice was significantly higher than in the standard PRT miceIn addition, FLASH proton radiotherapy retains a higher percentage of regenerative crypts than standard proton radiotherapyIn a further experiment, the researchers looked at the effects of two methods on intestinalfibrosis in miceand found that FLASH protons did not cause the common side effects of intestinal fibrosis FLASH dose radiation can better maintain the proliferation of intestinal cryptine and inhibit the formation of fibrosis
    in short, this is the first study to prove that the use of protons instead of electrons to produce FLASH doses and the current use of accelerated agents for clinical therapy is feasible Researchers have begun exploring how to turn the treatment into clinical trials, including the design of a FLASH delivery system that can be used in humans
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.